SYNERGISTIC ACTIVITY OF NKG2D-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS AND RADIOTHERAPY AGAINST GLIOMA

Weiss T.; Weller M.; Pruschy M.; Sentman C.; Roth P.

首页> 外文期刊>Neuro-Oncology >SYNERGISTIC ACTIVITY OF NKG2D-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS AND RADIOTHERAPY AGAINST GLIOMA

【24h】

SYNERGISTIC ACTIVITY OF NKG2D-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS AND RADIOTHERAPY AGAINST GLIOMA

机译：基于NKG2D的嵌合抗原受体（CAR）-T细胞的协同活性及抗胶质瘤的放射治疗

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Neuro-Oncology》 |2017年第3期|18-18|共1页
作者
Weiss T.; Weller M.; Pruschy M.; Sentman C.; Roth P.;
展开▼
作者单位

Univ Hosp Zurich, Zurich, Switzerland;

Univ Hosp Zurich, Zurich, Switzerland;

Univ Hosp Zurich, Zurich, Switzerland;

Geisel Sch Med, Lebanon, NH USA;

Univ Hosp Zurich, Zurich, Switzerland;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment [J] . Tao Kelong, He Meng, Tao Feng, Cancer chemotherapy and pharmacology. . 2018,第5期

机译：基于NKG2D的嵌合抗原受体-T细胞胃癌治疗的发展
2. T cells redirected to interleukin-13Rα2 with interleukin-13 mutein—chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1 [J] . SIMONE KREBS, KEVIN K.H. CHOW, ZHONGZHEN YI, Cytotherapy . 2014,第8期

机译：通过白细胞介素13突变蛋白重定向至白细胞介素13Rα2的T细胞—嵌合抗原受体具有抗神经胶质瘤活性，但也可识别白细胞介素13Rα1
3. NKG2D-Based CAR T Cells and Radiotherapy Exert Synergistic Efficacy in Glioblastoma [J] . Weiss Tobias, Weller Michael, Guckenberger Matthias, Cancer research: The official organ of the American Association for Cancer Research, Inc . 2018,第4期

机译：基于NKG2D的汽车T细胞和放射疗法在胶质母细胞瘤中施加协同效果
4. REMOVAL OF MYELOID CELLS FROM AUTOLOGOUS LEUKOCYTES USED FOR CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL MANUFACTURING IMPROVES FINAL PRODUCT CONSISTENCY AND YIELDS [C] . David Stroncek, Daniel W. Lee, Marianna Sabatino, Scale-up and manufacturing of cell-based therapies V . 2017

机译：从用于嵌合抗原受体（CAR）T细胞制造的自体白细胞去除髓样细胞可改善最终产品的一致性和产量
5. Targeting the Disialoganglioside GD2 with Chimeric Antigen Receptor T Cells for Immunotherapy in Diffuse Midline Gliomas, and Exploration of Neuron-OPC Synaptic Connectivity in the Context of Adaptive Myelination [D] . Mount, Christopher W. 2020

机译：用嵌合抗原受体T细胞靶向Diaialoganglioside GD2，用于在弥漫性中线胶质瘤中的免疫疗法，以及在适应性髓鞘中的背景下探索神经元-Popaptic连通性
6. OS09.3 Synergistic activity of NKG2D-based chimeric antigen receptor (CAR)-T cells and radiotherapy against glioma [O] . T. Weiss, M. Weller, M. Pruschy, 2017

机译：OS09.3基于NKG2D的嵌合抗原受体（CAR）-T细胞的协同活性和对神经胶质瘤的放射治疗
7. T cells redirected to interleukin-13Rα2 with interleukin-13 mutein–chimeric antigen receptors have anti-glioma activity but also recognize interleukin-13Rα1 [O] . Simone Krebs, Kevin K.H. Chow, Zhongzhen Yi, 2014

机译：用白细胞介素-13致命素 - 嵌合抗原受体重定向到白细胞介素-13Rα2具有抗胶质瘤活性，但也识别白细胞介素-13Rα1

SYNERGISTIC ACTIVITY OF NKG2D-BASED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS AND RADIOTHERAPY AGAINST GLIOMA

著录项

相似文献

相关主题

期刊订阅